| 000 | 01681 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513154708.0 | ||
| 264 | 0 | _c19990216 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVanhoefer, U | |
| 245 | 0 | 0 |
_ad,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cDec 1996 |
||
| 300 |
_a1961-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aButhionine Sulfoximine _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Resistance, Multiple |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aGenes, MDR _xphysiology |
| 650 | 0 | 4 |
_aGlutathione _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aCao, S | |
| 700 | 1 | _aMinderman, H | |
| 700 | 1 | _aToth, K | |
| 700 | 1 | _aSkenderis, B S | |
| 700 | 1 | _aSlovak, M L | |
| 700 | 1 | _aRustum, Y M | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 2 _gno. 12 _gp. 1961-8 |
|
| 999 |
_c9780372 _d9780372 |
||